Polyplus launches FectoVIR®-AAV GMP transfection reagent for large scale viral vector production
Polyplus invests in Shanghai commercial offices to expand localized cell and gene therapy sector supply
Polyplus-transfection acquires Biowire to further expand into Asia-Pacific gene and cell therapy markets
Polyplus-transfection initiates construction of Vectura, a new 4,000m2 facility